AgroScience Capital Group

Lenders request conversion of over €0.5mn in Mezzanine capital (convertible loans) into equity; resolution passed by the Board of Directors to facilitate conversion by means of approved capital increase

AgroScience Capital AG’s shareholders approve all proposals of the Board of Directors at the 2024 Annual General Meeting (AGM)

Update on “plant protection” IPR portfolio: ≈ 30 international patents granted (incl. China, India, Brazil, US, Canada, Japan, all major agricultural markets in Europe, Australia etc.) on our new active ingredient (from the alkylene guanidine group) with unique CAS number for fungicidal applications and proven broad diseases control spectrum of commercially relevant phytopathogens affecting major crops

AgroScience Capital AG secures over €0.5mn in Mezzanine capital (convertible loans)

Scientific evidence as to broad diseases control spectrum of AgroScience Capital AG’s proprietary active substance covering: (1) Venturia inaequalis (VENTIN), (2) Alternaria alternata (ALTEAL), (3) Neofabraea vagabunda (PEZIAL), (4) Sphaerotheca fuliginea (SPHRFU), (5) Zymoseptoria tritici (SEPTTR), (6) Botrytis cinerea (BOTRCI), (7) Fusarium avenaceum (GIBBAV), (8) Fusarium culmorum (FUSACU), (9) Fusarium graminearum (GIBBZE), (10) Phakopsora pachyrhizi (PHAKPA) and (11) Alternaria solani (ALTESOL).

AgroScience Capital AG launches broad based in-vitro and in-vivo (GH) efficacy programme with its improved “t.k.” design

AgroScience Capital AG improves “t.k.” design of its alkylene guanidine based active substance

AgroScience Capital AG’s shareholders approve all proposals of the Board of Directors at the 2023 Annual General Meeting (AGM)

AgroScience Capital AG secures € 1.2 million in Equity / Venture Capital (as part of its Seed financing round) through private placement

At this year’s ordinary Annual General Meeting (AGM) AgroScience Capital AG’s shareholders approve all proposals of the Board of Directors

AgroScience Capital Group is pleased to announce the assignment of a completely new, own CAS Registry Number® (CAS RN®) to its proprietary liquid NPK fertilizer by CAS (a division of the AMERICAN CHEMICAL SOCIETY); Our globally scalable liquid NPK fertilizer (1) is produced climate-friendly (resource- and energy-efficiently with zero CO2 emission) and (2) is highly environmental-friendly (i.e., free of chloride, nitrate and polyphosphate as well as pollutants and organic or inorganic impurities). A unique differentiator. Our syntheses and products are designed to support global agriculture to climate-friendly transform into a more green and sustainable industry.

AgroScience Capital Group is delighted to learn that it has been highlighted by “StartUs Insights” as one of the Top 5 AgriTech Start-Ups (out of 417) on their current “Global Start-Up Heat Map”:

AgroScience Capital Group announces the international (PCT) patent registration of a new, disruptive and proven route of synthesis of liquid fertilizers (2nd Strategic Business Area) which enables the CLIMATE-FRIENDLY PRODUCTION (i.e., highly ENERGY-efficient AND CO2-neutral production) of ENVIRONMENTAL-FRIENDLY LIQUID (NPK) FERTILIZERS. By bringing this innovation to market, participants (producers, wholesalers / retailers, farmers and consumers) in this global industry can be given an ECOLOGICAL CHOICE and an INDIVIDUAL OPPORTUNITY for environmental contributions

AgroScience Capital AG announces raising CHF 1.2 million in Equity / Venture Capital (as part of its Seed financing round) through private placements

At this year’s ordinary Annual General Meeting (AGM) AgroScience Capital AG’s shareholders approved all proposals of the Board of Directors

AgroScience Capital AG announces raising CHF 2.2 million in Equity / Venture Capital (as part of its Seed financing round) through private placements

AgroScience Capital AG announces assignment of a new, own CAS Registry Number® (CAS RN®) to its proprietary, internationally patent protected chemical (active) substance by CAS (a division of the AMERICAN CHEMICAL SOCIETY); the CAS RN® is assigned to “unique, new substances” and is an “authoritative global industry standard”

AgroScience Capital AG’s shareholders unanimously re-elect all Members of the Board of Directors at the Adjourned Annual General Meeting 2020. The AGM was held by electronic means due to COVID-19

AgroScience Capital AG announces establishing of “AgroScience Capital Deutschland GmbH” as its wholly-owned subsidiary company in Germany

Scientific article in renowned international agricultural publication on our proprietary active substance (in German; Copyrights European Fruit Magazine June, 2020)

Scientific article in renowned international agricultural publication on our proprietary active substance (in German; Copyrights Obstbau May, 2020)

OECD 473 non-GLP (Skin irritation) study result: AgroScience Capital AG’s active ingredient evaluated as not skin-irritating

Scientific article in renowned international agricultural publication on our proprietary active substance (in German; Copyrights Obstbau April, 2020)

Segment Fungicides: 1st yr GEP efficacy field trials against powdery mildew (SPHRFU) on cucumber successful

Segment Fungicides: 1st yr GEP efficacy field trials against downy mildew of cucurbits (PSPECU) on cucumber successful

Segment Fungicides: 1st yr GEP efficacy field trials against speckled leaf blotch of wheat (SEPTTR) on winter wheat successful

Segment Fungicides: 1st yr GEP efficacy field trials against powdery mildew of cereals (ERYSGR) on winter wheat successful

OECD 471 non-GLP (Mutagenicity) study result: AgroScience Capital AG’s active ingredient evaluated as non mutagenic in AMES test

Segment Fungicides: 1st yr GEP efficacy field trials against downy mildew (PLASVI) on grapevine successful

Segment Bactericides: 3rd year GEP efficacy field trials against fire blight (ERWIAM) on apple very successful

Shareholders approve financial statements 2018 at Annual General Meeting in Zurich

OECD 107 non-GLP (Partition Coefficient (n-Octanol / Water)) study result: AgroScience Capital AG’s active ingredient evaluated non bioaccumulative

AgroScience Capital AG’s financial statements (as per IFRS & Swiss CO) for the reporting period 2018 audited by KPMG

Segment Fungicides: AgroScience Capital AG extends international GEP efficacy field trials programme to the areas of fruit-, vegetable-, cereals- and oilseed-crops

Company’s shareholder base at 20 private and institutional members

AgroScience Capital AG recommences R&D operations on its new, automated and state-of-the-art laboratory reactor system and analytical instruments

AgroScience Capital AG moves into new laboratory premises post technical tenant fit-out, inspection and receipt of operating license

AGM of AgroScience Capital AG: Shareholders approve financial statements for the extended financial year 2016-2017 at Annual General Meeting in Zurich

AgroScience Capital AG’s financial statements (as per IFRS & Swiss CO) for the extended financial year 2016-2017 audited

AgroScience Capital AG announces raising approx. CHF 1.5 million in Equity / Venture Capital and an additional approx. CHF 0.5 million Mezzanine (as part of its Seed financing round) through private placements

EGM passes resolutions on increase of approved share capital and selection of KPMG AG (Zug, Switzerland) as audit firm

Segment Bactericides: 2nd year GEP efficacy field trials against fire blight (ERWIAM) on apple very successful

Segment Bactericides: MIC tests against +5 commercially relevant bacteria very successfully completed

OECD 213 and 214 (acute oral and contact toxicity) study results on honey bees (Apis mellifera L.): classification “non-toxic to bees”

AgroScience Capital AG selects PricewaterhouseCoopers AG , Zug (PwC) for corporate financial services

AgroScience Capital AG announces raising approx. CHF 0.5 million in Equity / Venture Capital (as part of its Pre-Seed financing round) through private placements

Segment Fungicides: Greenhouse efficacy tests against +5 commercially relevant funguses very successfully completed

Segment Bactericides: entry into 2nd business segment with very successful 1st year GEP efficacy field trails against fire blight (ERWIAM) on apple

AgroScience Capital AG selects Homburger for legal advisory

Segment Fungicides: 2nd yr GEP efficacy field trials against scab of apple (VENTIN) on apple very successful

AgroScience Capital AG completes corporate design & communication concept

AgroScience Capital AG selected to present at SECA’s international start-up pitching event “Morning of Sevens”

Lit.research by EUROFINS on active ingredient: no hits of concern for indicated “cut-off” under Regulation (EC) 1107/2009 and Regulation (EC)1907/2006 (REACH)

AgroScience Capital AG announces raising approx. CHF 0.5 million in Equity / Venture Capital (as part of its Pre-Seed financing round) through private placements

EGM passes resolution on creation of approved share capital

Incorporation of AgroScience Capital AG